688
Views
15
CrossRef citations to date
0
Altmetric
Review

Therapeutic strategies for treating epilepsy during pregnancy

&
Pages 323-332 | Received 23 Aug 2018, Accepted 15 Nov 2018, Published online: 10 Dec 2018

References

  • Hauser WA, Annegers JF. Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc. 1996 Jun;71(6):576–586. Review.
  • Epilepsy Foundation Epilepsy and pregnancy 2014. [cited 2018 Oct 31]. Available from: http://www.epilepsy.com/information/women/epilepsy-and-pregnancy.
  • Yerby M. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia. 2003;44(Suppl 3):33–40.
  • Harden C, Hopp J, Ting T, et al. Practice Parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency. Neurology. 2009;73:126–132.
  • Dansky LV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folicacid and antiepileptic therapy. Neurology. 1992 Apr;42(4 Suppl 5):32–42. Review.
  • Morrow J, Hunt S, Russell A, et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry. 2009 May;80(5):506–511.
  • Pittschieler S, Brezinka C, Jahn B, et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol. 2008 Dec;255(12):1926–1931.
  • Asadi-Pooya A, Ghetmiri E. Folic acid supplementation reduces the development of some blood cell abnormalities in children receiving carbamazepine. Epilepsy Behav. 2006 Feb;8(1):228–231.
  • Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013 Mar;12(3):244–252.
  • Husebye ESN, Gilhus NE, Riedel B, et al. Verbal abilities in children of mothers with epilepsy: association to maternal folate status. Neurology. 2018 Aug 28;91(9):e811–e821.
  • Henry LA, Cassidy T, McLaughlin M, et al. Acid Supplementation throughout pregnancy: psychological developmental benefits for children. Acta Paediatr. 2018 Aug;107(8):1370–1378.
  • Tomson T, Battino D, Bonizzoni E, et al. Dose- dependent teratogenicity of valproate in mono- and polytherapy. Neurology. 2015;85:866–872.
  • Thomas SV, Syam U, Devi JS. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia. 2012 May;53(5):e85–8.
  • Vajda FJ, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia. 2008 Jan;49(1):172–176.
  • Abe K, Hamada H, Yamada T, et al. Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes. Seizure. 2014 Feb;23(2):112–116.
  • Battino D, Tomson T, Bonizzoni E, et al. EURAP Study Group. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia. 2013 Sep;54(9):1621–1627.
  • Sveberg L, Svalheim S, Taubøll E. The impact of seizures on pregnancy and delivery. Seizure. 2015 May;28:35–38.
  • Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology. 1998 Sep;51(3):904–906.
  • Sahoo S, Klein P. Maternal complex partial seizure associated with fetal distress. Arch Neurol. 2005 Aug;62(8):1304–1305.
  • Vale T, Da Silva A, Lima D, et al. Seizures during pregnancy modify the development of hippocampal interneurons of the offspring. Epilepsy Behav. 2010 Sep;19(1):20–25.
  • Rauchenzauner M, Ehrensberger M, Prieschl M, et al. Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy–a matter of importance for the baby? J Neurol. 2013 Feb;260(2):484–488.
  • Minkoff H, Schaffer RM, Delke I, et al. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet Gynecol. 1985 Mar;65(3 Suppl):22S–24S.
  • Cummings C, Stewart M, Stevenson M, et al. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child. 2011 Jul;96(7):643–647.
  • Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1575–1583.
  • Campbell E, Kennedy F, Russell A, et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland epilepsy and pregnancy registers. J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1029–1034.
  • Tomson T, Battino D, Bonizzoni E, et al. Comparitive risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17:530–538.
  • Hernández-Díaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. North American AED pregnancy registry; North American AED pregnancy registry. Neurology. 2012 May 22;78(21):1692–1699.
  • Thomas SV, Jose M, Divakaran S, et al. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India. Epilepsia. 2017 Feb;58(2):274–281.
  • Vajda F, O’Brien T, Graham J, et al. The Australian register of antiepileptic drugs in pregnancy: changes over time in the epileptic population. J Clin Neurosci. 2014 Sep;21(9):1478–1482.
  • Cunnington MC, Weil JG, Messenheimer JA, et al. Final results from 18 years of the international lamotrigine pregnancy registry. Neurology. 2011 May 24; 76(21):1817–1823.
  • Veiby G, Daltveit AK, Engelsen BA, et al. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J Neurol. 2014 Mar;261(3):579–588.
  • De Wais P, Mastroiacovo P, Weatherall JAC, eds. EUROCAT guide for the registration of congenital abnormalities. Brussels: European Union; 1984.
  • Weston J, Bromley R, Jackson CF, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2016 Nov;7(11):CD010224.
  • Fried S, Kozer E, Nulman I, et al. Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf. 2004;27(3):197–202.
  • Holmes LB, Baldwin EJ, Smith CR, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology. 2008 May 27;70(22 Pt 2):2152–2158.
  • Dolk H, Wang H, Loane M, et al. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology. 2016 May 3;86(18):1716–1725.
  • Tomson T, Xue H, Battino D. Major congenital malformations in children of women with epilepsy. Seizure. 2015 May;28:46–50.
  • Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):193–198.
  • Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK epilepsy and pregnancy register;UK epilepsy and pregnancy register. Neurology. 2008 Jul 22;71(4):272–276.
  • Mawhinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology. 2013 Jan 22;80(4):400–405.
  • New measures to avoid valproate exposure in pregnancy endorsed. EMA/145600/2018. Available from: http://www.ema.europa.eu
  • Vajda FJE, O’Brien TJ, Graham JE, et al. Valproate-associated foetal malformations-Rates of occurrence, risks in attempted avoidance. Acta Neurol Scand. 2018 Aug 14. [Epub ahead of print]. DOI:10.1111/ane.13005.
  • Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol. 2016 Feb;15(2):210–218.
  • Tomson T, Marson A, Boon P, et al. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia. 2015;56(7):1006–1019.
  • Vajda FJE, O’Brien TJ, Graham JE, et al. Antiepileptic drug polytherapy in pregnant women with epilepsy. Acta Neurol Scand. 2018 Aug;138(2):115–121.
  • Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000 Jul;37(7):489–497.
  • Strömland K, Nordin V, Miller M, et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol. 1994 Apr;36(4):351–356.
  • Weissenberger S, Ptacek R, Klicperova-Baker M, et al. Lifestyles and comorbidities: A call for an holistic perspective - from medical to societal intervening factors. Front Psychol. 2017 Apr;6(8):454.
  • Guizzetti M, Zhang X, Goeke C, et al. Glia and neurodevelopment: focus on fetal alcohol spectrum disorders. Front Pediatr. 2014 Nov 11;2:123.
  • Sattler JM. Assessment of children: cognitive foundations. 5th ed. San Diego, CA: Jerome M Sattler; 2008.
  • Baker GA, Bromley RL, Briggs M, et al. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Liverpool and manchester neurodevelopment group. Neurology. 2015 Jan 27;84(4):382–390.
  • Shallcross R, Bromley RL, Cheyne CP, et al. Liverpool and manchester neurodevelopment group; In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. UK epilepsy and pregnancy register. Neurology. 2014 Jan 21;82(3):213–221.
  • Bromley RL, Mawer GE, Briggs M, et al. Liverpool and manchester neurodevelopment group. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):637–643.
  • Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013 Apr 24;309(16):1696–1703.
  • Kim J, Kondratyev A, Gale K. Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther. 2007 Oct;323(1):165–173.
  • Kim JS, Kondratyev A, Tomita Y, et al. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia. 2007;48(Suppl 5):19–26.
  • Forcelli PA, Kim J, Kondratyev A, et al. Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain. Epilepsia. 2011 Dec;52(12):e207–11.
  • Rinaldi T, Silberberg G, Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex. 2008 Apr;18(4):763–770. Epub 2007 Jul 17.
  • Sui L, Chen M. Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories. Brain Res Bull. 2012 Apr 10;87(6):556–563.
  • Katz I, Kim J, Gale K, et al. Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther. 2007 Aug;322(2):494–500.
  • Dean J, Robertson Z, Reid V, et al. Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR. Am J Med Genet A. 2007 Oct 1;143A(19):2303–2311.
  • Vajda FJ, O’Brien TJ, Lander CM, et al. Teratogenesis in repeated pregnancies in antiepileptic drug-treated women. Epilepsia. 2013 Jan;54(1):181–186.
  • Johnson EL, Stowe ZN, Ritchie JC, et al. Carbamazepine clearance and seizure stability during pregnancy. Epilepsy Behav. 2014;33:49–53.
  • Reisinger TL, Newman M, Loring DW, et al. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav. 2013 Oct;29(1):13–18.
  • Pennell P, Peng L, Newport D, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology. 2008 May 27;70(22 Pt 2):2130–2136.
  • Polepally AR, Pennell PB, Brundage RC, et al. Model-based lamotrigine clearance changes during pregnancy: clinical implication. Ann Clin Transl Neurol. 2014 Feb;1(2):99–106.
  • Tomson T, Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet. 2007;46:209–219.
  • Westin A, Reimers A, Helde G, et al. Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure. 2008;17: 192–198. Epilepsy Behav. 2014 Apr;33:49-53.
  • Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia. 2013 Mar;54(3):405–414.
  • NICE. Epilepsies, the diagnosis and management of epilepsies in adults and children in primary and secondary care. In: Clinical guideline, p. 20. London: NICE; 2004.
  • Taubøll E, Gjerstad L, Henriksen T, et al. Women and epilepsy. Tidsskr Nor Laegeforen. 2003 Jun 12;123(12):1691–1694.
  • Richmond JR, Krishnamoorthy P, Andermann E, et al. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol. 2004 Feb;190(2):371–379.
  • Donaldson J. Neurological disorders. In: de Swiet M, editor. Medical disorders in obstetric practice. 4th ed. Oxford: Blackwell Science; 2002. p. 486–489.
  • Schlick K, Hemmen T, Lyden P. Seizures and meperidine: overstated and underutilized. Ther Hypothermia Temp Manag. 2015 Dec;5(4):223–227. . Epub 2015 Jun 18.
  • Rodier P. Developing brain as a target of toxicity. Environ Health Perspect. 1995 Sep;103(Suppl 6):73–76.
  • Meador KJ, Baker GA, Browning N, et al. Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study group. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014 Aug;168(8):729–736.
  • Pennell P. Use of antiepileptic drugs during pregnancy: evolving concepts. Neurotherapeutics. 2016 Oct;13(4):811–820.
  • Hernández-Díaz S, McElrath TF, Pennell PB, et al. North American antiepileptic drug pregnancy registry. Fetal growth and premature delivery in pregnant women on antiepileptic drugs. Ann Neurol. 2017 Sep;82(3):457–465.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.